• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SVP, Entertainment Couling John D sold $50,652 worth of shares (675 units at $75.04), decreasing direct ownership by 0.55% to 121,151 units (SEC Form 4)

    5/7/25 4:47:24 PM ET
    $DLB
    Multi-Sector Companies
    Miscellaneous
    Get the next $DLB alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Couling John D

    (Last) (First) (Middle)
    C/O DOLBY LABORATORIES, INC.
    1275 MARKET STREET

    (Street)
    SAN FRANCISCO CA 94103

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    Dolby Laboratories, Inc. [ DLB ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    Director 10% Owner
    X Officer (give title below) Other (specify below)
    SVP, Entertainment
    3. Date of Earliest Transaction (Month/Day/Year)
    05/05/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Class A Common Stock 05/05/2025 S 675 D $75.04 121,151(1) D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. Shares held following the reported transaction includes 48,526 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
    /s/ Daniel Rodriguez as Attorney-in-Fact for John Couling 05/07/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $DLB alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DLB

    DatePrice TargetRatingAnalyst
    6/3/2024$100.00Mkt Perform → Outperform
    Barrington Research
    11/18/2022Outperform → Mkt Perform
    Barrington Research
    5/24/2022$90.00Buy
    Rosenblatt
    8/2/2021$115.00Mkt Perform → Outperform
    Barrington Research
    More analyst ratings

    $DLB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      11/13/24 4:05:17 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SC 13G/A filed by Dolby Laboratories

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      9/10/24 4:39:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form SC 13G/A filed by Dolby Laboratories (Amendment)

      SC 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      2/13/24 5:02:35 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President and CEO Yeaman Kevin J bought $200 worth of shares (3 units at $78.15) (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      6/25/24 9:28:41 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    SEC Filings

    See more

    $DLB
    Financials

    Live finance-specific insights

    See more
    • SEC Form 10-Q filed by Dolby Laboratories

      10-Q - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:52:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories filed SEC Form 8-K: Results of Operations and Financial Condition

      8-K - Dolby Laboratories, Inc. (0001308547) (Filer)

      5/1/25 4:15:23 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Amendment: SEC Form SCHEDULE 13G/A filed by Dolby Laboratories

      SCHEDULE 13G/A - Dolby Laboratories, Inc. (0001308547) (Subject)

      4/30/25 10:55:37 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Reports First Quarter 2025 Financial Results

      SAN FRANCISCO, Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories. "In Q1, Dolby Atmos and Dolby Vision momentum continued across device categories. At CES, many of our device partners announced a wide range of Dolby enabled products, and customers experienced the first Dolby Vision enabled car with Li Auto." First Quarter Fiscal 2025 Financial Highlights Total revenue was $357 mil

      1/29/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Leadership Updates

    Live Leadership Updates

    See more
    • OpenSesame Appoints Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors

      OpenSesame today announced it has appointed Tamar Elkeles, PhD, and Emily Rollins to its Board of Directors. Dr. Elkeles is a highly regarded Chief Human Resources Officer and thought leader, advising globally on Talent, Learning, Human Resources, and Organization Development. Ms. Rollins has served hundreds of companies during her career at Deloitte, where she held various leadership positions in their U.S. Technology, Media, and Telecommunications practice, Audit Innovation and Transformation, and Diversity and Inclusion initiatives. Both executives bring decades of experience in technology, talent, finance, and governance to OpenSesame. Dr. Elkeles has spent 30 years in the human capit

      8/10/22 9:00:00 AM ET
      $DLB
      $GPX
      $SNCE
      $XMTR
      Multi-Sector Companies
      Miscellaneous
      Other Consumer Services
      Consumer Services
    • Dolby Laboratories Announces Dr. Shriram Revankar as SVP Advanced Technology Group

      SAN FRANCISCO, May 03, 2022 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, today announced the appointment of Dr. Shriram Revankar, a technologist and industry leader who has cultivated teams across multiple disciplines to deliver high impact technologies and world-class research, as its Senior Vice President Advanced Technology Group. Shriram will lead Dolby's global Advanced Technology Group building on the company's decades of innovation. Most recently, as Vice President and Fellow at Adobe, Shriram founded several of Adobe's global research labs, including the Big-Data Experience Lab and the Document Intelligence Lab. Through

      5/3/22 12:00:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Appoints Tony Prophet to its Board of Directors

      SAN FRANCISCO, Dec. 08, 2021 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) announced today the appointment of Tony Prophet to its Board of Directors, effective December 6, 2021. Over the course of many years, Tony has established himself as a technology industry leader who has helped guide companies across multiple disciplines. Most recently, Tony served as the Chief Equality and Recruiting Officer at Salesforce, co-chairing the Salesforce Racial Equality and Justice Task Force, created to help drive systemic change in the workplace and community. He was also a co-founder of the company's Ethical and Humane Use of technology initiative. During his time with Microsoft, Tony serve

      12/8/21 8:30:00 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Entertainment Couling John D sold $50,652 worth of shares (675 units at $75.04), decreasing direct ownership by 0.55% to 121,151 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      5/7/25 4:47:24 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SEC Form 4 filed by President and CEO Yeaman Kevin J

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/28/25 4:04:04 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • SVP, Chief Marketing Officer Pendleton Todd exercised 7,286 shares at a strike of $71.07 and sold $1,517,668 worth of shares (18,121 units at $83.75), decreasing direct ownership by 23% to 37,290 units (SEC Form 4)

      4 - Dolby Laboratories, Inc. (0001308547) (Issuer)

      2/21/25 5:17:52 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Dolby Laboratories Reports Second Quarter 2025 Financial Results

      SAN FRANCISCO, May 1, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the second quarter of fiscal 2025. "We had a strong second quarter with continued momentum across our end markets, especially in Auto and Mobile," said Kevin Yeaman, President and CEO, Dolby Laboratories. "While there is economic uncertainty, we are well positioned to operate across a range of scenarios. We are in a strong financial position, we continue to see strong engagement from our ecosystem, and we remain focused on driving long-term growth.

      5/1/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results

      SAN FRANCISCO, April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, May 1, 2025. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-21

      4/8/25 4:15:00 PM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027

      AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan., March 31, 2025 /PRNewswire/ --  Dolby Laboratories, Inc. (NYSE:DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE:AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience. Beginning this year, AMC and Dolby will add an additional 40 Dolby Cinema at AMC locations in the United States through the end of 2027.

      3/31/25 8:30:00 AM ET
      $AMC
      $DLB
      Movies/Entertainment
      Consumer Discretionary
      Multi-Sector Companies
      Miscellaneous

    $DLB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Dolby Labs upgraded by Barrington Research with a new price target

      Barrington Research upgraded Dolby Labs from Mkt Perform to Outperform and set a new price target of $100.00

      6/3/24 9:17:02 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Dolby Labs downgraded by Barrington Research

      Barrington Research downgraded Dolby Labs from Outperform to Mkt Perform

      11/18/22 9:17:35 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous
    • Rosenblatt initiated coverage on Dolby Labs with a new price target

      Rosenblatt initiated coverage of Dolby Labs with a rating of Buy and set a new price target of $90.00

      5/24/22 7:27:36 AM ET
      $DLB
      Multi-Sector Companies
      Miscellaneous